SLDB
Income statement / Annual
Last year (2024), Solid Biosciences Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2024, Solid Biosciences Inc.'s net income was -$124.70 M.
See Solid Biosciences Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$0.00 |
$0.00 |
$8.09 M |
$13.62 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$2.46 M
|
$2.58 M
|
$0.00
|
$0.00
|
$3.92 M
|
$2.82 M
|
$1.57 M
|
$0.00
|
$56.00 K
|
$0.00
|
| Gross Profit |
-$2.46 M
|
-$2.58 M
|
$8.09 M
|
$13.62 M
|
-$3.92 M
|
-$2.82 M
|
-$1.57 M
|
-$448.00 K
|
-$56.00 K
|
$0.00
|
| Gross Profit Ratio |
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$96.43 M
|
$76.56 M
|
$78.42 M
|
$58.74 M
|
$64.88 M
|
$94.74 M
|
$57.97 M
|
$39.91 M
|
$20.12 M
|
$4.19 M
|
| General & Administrative Expenses |
$33.30 M
|
$27.75 M
|
$28.95 M
|
$27.14 M
|
$21.58 M
|
$24.58 M
|
$17.72 M
|
$14.95 M
|
$5.46 M
|
$2.37 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$33.30 M
|
$27.75 M
|
$28.95 M
|
$27.14 M
|
$21.58 M
|
$24.58 M
|
$17.72 M
|
$14.95 M
|
$5.46 M
|
$2.37 M
|
| Other Expenses |
-$2.46 M
|
-$2.58 M
|
$7.18 M
|
$0.00
|
-$3.92 M
|
$0.00
|
$270.00 K
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$127.27 M
|
$101.73 M
|
$114.55 M
|
$85.87 M
|
$82.54 M
|
$119.32 M
|
$75.69 M
|
$54.86 M
|
$25.58 M
|
$6.56 M
|
| Cost And Expenses |
$129.73 M
|
$104.32 M
|
$114.55 M
|
$85.87 M
|
$86.46 M
|
$119.32 M
|
$75.69 M
|
$54.86 M
|
$25.58 M
|
$6.56 M
|
| Interest Income |
$9.47 M
|
$7.14 M
|
$2.62 M
|
$64.00 K
|
$115.00 K
|
$1.58 M
|
$619.00 K
|
$219.00 K
|
$369.00 K
|
$3.00 K
|
| Interest Expense |
$340.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$2.46 M
|
$2.58 M
|
$2.41 M
|
$2.96 M
|
$3.92 M
|
$2.82 M
|
$1.57 M
|
$448.00 K
|
$56.00 K
|
$6.56 M
|
| EBITDA |
-$121.90 M |
-$93.43 M |
-$96.87 M |
-$69.29 M |
-$84.37 M |
-$116.49 M |
-$75.69 M |
-$54.41 M |
-$25.52 M |
$119.00 K |
| EBITDA Ratio |
0
|
0
|
-11.97
|
-5.09
|
0
|
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
-13.15
|
-5.3
|
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$5.03 M
|
$8.30 M
|
$20.47 M
|
$66.00 K
|
-$1.83 M
|
$2.10 M
|
$889.00 K
|
$1.68 M
|
$1.80 M
|
-$100.00 K
|
| Income Before Tax |
-$124.70 M
|
-$96.02 M
|
-$85.98 M
|
-$72.19 M
|
-$88.29 M
|
-$117.22 M
|
-$74.80 M
|
-$53.18 M
|
-$23.77 M
|
-$6.66 M
|
| Income Before Tax Ratio |
0
|
0
|
-10.62
|
-5.3
|
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$124.70 M
|
-$96.02 M
|
-$85.98 M
|
-$72.19 M
|
-$88.29 M
|
-$117.22 M
|
-$74.80 M
|
-$52.12 M
|
-$21.54 M
|
-$6.38 M
|
| Net Income Ratio |
0
|
0
|
-10.62
|
-5.3
|
0
|
0
|
0
|
0
|
0
|
0
|
| EPS |
-3.06 |
-4.83 |
-10.1 |
-10.14 |
-25.5 |
-43.05 |
-33.73 |
-24.26 |
-16.8 |
-4.97 |
| EPS Diluted |
-3.06 |
-4.83 |
-10.1 |
-10.14 |
-25.5 |
-43.05 |
-33.73 |
-24.26 |
-16.8 |
-4.97 |
| Weighted Average Shares Out |
$40.82 M
|
$19.88 M
|
$8.51 M
|
$7.12 M
|
$3.46 M
|
$2.69 M
|
$2.22 M
|
$2.15 M
|
$1.28 M
|
$1.28 M
|
| Weighted Average Shares Out Diluted |
$40.82 M
|
$19.88 M
|
$8.51 M
|
$7.12 M
|
$3.46 M
|
$2.69 M
|
$2.22 M
|
$2.15 M
|
$1.28 M
|
$1.28 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
